Skip to content

Perioperative Research Into Memory: Cognitive Outcome Following Major Burns

Using Cognitive Tests and Functional MRI to Investigate Long Term Cognitive Dysfunction Following a Critical Illness Due to a Major Burn Injury

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03470844
Acronym
PRiMe
Enrollment
32
Registered
2018-03-20
Start date
2015-08-05
Completion date
2017-10-30
Last updated
2018-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Injury

Keywords

Major burns, Intensive Care Medicine, Neurocognitive dysfunction, Functional magnetic resonance imaging, Neuroinflammation, Long term quality of life

Brief summary

The long term survival of patients who require admission to critical care (CC) following a major burn injury (MBI) continues to improve with advanced clinical management. There has been increasing interest into cognitive dysfunction (CD) due to neuroinflammation (NI) following CC, anaesthesia, surgery, and the association of NI with diseases characterised by CD such as Alzheimer's disease. Patients who suffer a MBI and who subsequently require admission to CC will be at uniquely high risk for CD. MBI produces an exaggerated and prolonged systemic inflammatory response, with NI demonstrated in animal models. Additionally NI can be exaggerated by insults such as sepsis, anaesthesia, and surgical trauma, common and often necessary following MBI. The aim of this study is to identify CD using cognitive tests to examine for deficits in working memory and executive function. Test proposed to use are the Hopkins Verbal Learning and Verbal Fluency tests, and a validated computerised battery (CogState). Neuroinflammation and underlying pathophysiology using fMRI and spectroscopy, known to demonstrate biomarkers for CD and NI. QoL will be assessed using the validated EQ-5D tool. The Inclusion criteria; patients who survive their burns injury (greater than 15% total body surface area) and require mechanical ventilation. Primary exclusion criteria; admission with toxic epidermal necrolysis syndrome, and evidence of head trauma.

Detailed description

This is a novel, proof of principle, prospective, cohort design, observational clinical study to assess for functional brain reorganisation, structural changes and long-term cognitive dysfunction following major burns injury and intensive care admission. The hypothesis is that following a major burns injury and intensive care admission patients will have neurocognitive dysfunction and demonstrable functional alterations seen on functional MRI due to neuroinflammation as a result of the primary injury and subsequent inflammatory insults.

Interventions

BEHAVIORALFace-to-face neurocognitive tests

Assessment of attention, processing speed, working memory and executive function

BEHAVIORALPsychological screening

Screening for the symptoms of depression, anxiety and post-traumatic stress disorder

OTHERfMRI

Brain volume, chemical markers, functional outcome

BEHAVIORALQuality of Life Self-Assessment data

EQ-5D will be converted into a utility score using standard EQ-5D UK tariffs

Sponsors

Imperial College Healthcare NHS Trust
CollaboratorOTHER
University of Westminster
CollaboratorOTHER
Chelsea and Westminster NHS Foundation Trust
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
16 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Survival following admission to Chelsea and Westminster Burns Intensive Care Unit between 2004-2013 with a burn injury \> 15% total body surface area, requiring intubation and ventilation

Exclusion criteria

* Patients under 16. * Patients with toxic epidermal necrolysis syndrome or evidence of head trauma. * Patients with evidence of risk to psychological safety from inclusion in study: any patient currently held under section of the Mental Health Act, any patient receiving formal psychiatric treatment (including involvement in a Personality Disorder Unit, being under voluntary section, current re-occurrence of chronic self harm), any patient currently detained at her Majesty's pleasure, any current substance abuse, or at the discretion of professional opinion following historical assessment of notes. - Patients with contraindications to MRI (patients with non-compatible pacemakers, patients with metallic foreign bodies e.g. metal sliver in their eye, patients with non-compatible surgical metal work, patients with severe claustrophobia). * Patient refusal or inability to give full informed consent. * Patients unable to understand plain verbal or written English.

Design outcomes

Primary

MeasureTime frameDescription
Neurocognitive function5 yearsSpecifically to investigate cognitive tasks using a battery of computerised tests.

Secondary

MeasureTime frameDescription
Neuroinflammatory changes analysis.5 yearsFunctional MRI scan

Other

MeasureTime frameDescription
Long-term quality of Life5 yearsEQ-5D

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026